Highly active antiretroviral therapy and socioeconomic inequalities in AIDS mortality in Spain

European Journal of Public Health

Volumn 17, Issue 2, 2007, Pages 231-

  Harper, Sam ^a   Lynch, John ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; EDUCATION; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; LETTER; MORTALITY; PRIORITY JOURNAL; PUBLIC HEALTH; SOCIOECONOMICS; SPAIN; TREATMENT RESPONSE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HEALTH SERVICES ACCESSIBILITY; HUMANS; SOCIOECONOMIC FACTORS; SPAIN;

EID: 34047239559     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckl278     Document Type: Letter

References (5)

1. Borrell C, Rodriguez-Sanz M, Pasarin MI, et al. AIDS mortality before and after the introduction of highly active antiretroviral therapy: does it vary with socioeconomic group in a country with a National Health System? Eur J Public Health 2006;16:601-8.
2. Harper S, Lynch J. Measuring health inequalities. In: Oakes JM, Kaufman JS, editors, Methods in Social Epidemiology. San Francisco: Jossey-Bass, 2006.
3. Lynch J, Davey Smith G, Harper S, Bainbridge K. Explaining the social gradient in coronary heart disease: comparing relative and absolute risk approaches. J Epidemiol Commun Health 2006;60:436-41.
4. Vågerö D, Erikson R. Socioeconomic inequalities in morbidity and mortality in western Europe. Lancet 1997;350:516.
5. Duggan MG, Evans WN. Estimating the impact of medical innovation: the case of HIV antiretroviral treatments. Cambridge, MA: National Bureau of Economic Research, 2005. Available at: http://papers.nber.org/papers/w11109.pdf.